撒哈拉以南非洲MSM和跨性别女性HIV耐药、系统发育与重叠感染分析:HPTN 075研究
HPTN 075研究在肯尼亚、马拉维和南非招募MSM和跨性别女性,对124例现患病例和21例血清阳转者进行HIV基因分型和耐药检测。结果显示主要亚型为A1和C,21/144(14.6%)携带主要耐药突变,最常见的为K103N和M184V/I;系统发育分析识别11个簇,1例现患病例和2例血清阳转者发现重叠感染,血清阳转者重叠感染年发病率高于现患病例及原发感染率。
要点
- MSM和跨性别女性中主要耐药突变为K103N和M184V/I,总耐药率14.6%。
- 系统发育分析识别11个传播簇,提示局部传播网络。
- 重叠感染在血清阳转者中更常见,年发病率高于原发感染。
核心结论
- 该研究揭示了撒哈拉以南非洲MSM和跨性别女性中HIV遗传多样性、耐药及重叠感染情况,可为未来预防干预提供参考。
研究设计与样本
- HPTN 075研究在肯尼亚、马拉维和南非招募MSM和跨性别女性,对124例现患病例和21例血清阳转者进行HIV基因分型和耐药检测,并利用Cluster Picker识别pol簇,通过下一代测序纵向分析env和pol序列评估重叠感染。
主要发现
- 123/124例现患病例和全部21例血清阳转者HIV基因分型成功,主要亚型为A1(肯尼亚)和C(马拉维和南非)。
- 144例参与者中21例(14.6%)检出主要耐药突变,最常见为K103N和M184V/I。
- 系统发育分析识别11个簇(2-6人),包括仅血清阳转者(n=1)、现患病例与血清阳转者混合(n=4)及仅现患病例(n=6)。
- 1例现患病例和2例血清阳转者发现重叠感染,血清阳转者重叠感染年发病率高于现患病例,且高于队列原发HIV感染率。
临床怎么用
- 在MSM和跨性别女性等高危人群中应关注HIV耐药监测和重叠感染风险,以指导预防干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The HIV Prevention Trials Network (HPTN) 075 study evaluated the feasibility of enrolling and retaining men who have sex with men (MSM) and transgender women (TGW) from Kenya, Malawi, and South Africa. During the study follow-up, 21 participants acquired human immunodeficiency virus (HIV) (seroconverters). We analyzed HIV subtype diversity, drug resistance, transmission dynamics, and HIV superinfection data among MSM and TGW enrolled in HPTN 075. METHODS: HIV genotyping and drug resistance testing were performed for participants living with HIV who had viral loads >400 copies/mL at screening (prevalent cases, n = 124) and seroconverters (n = 21). HIV pol clusters were identified using Cluster Picker. Superinfection was assessed by a longitudinal analysis of env and pol sequences generated by next-generation sequencing. RESULTS: HIV genotyping was successful for 123/124 prevalent cases and all 21 seroconverters. The major HIV subtypes were A1 (Kenya) and C (Malawi and South Africa). Major drug resistance mutations were detected in samples from 21 (14.6%) of 144 participants; the most frequent mutations were K103N and M184V/I. Phylogenetic analyses identified 11 clusters (2-6 individuals). Clusters included seroconverters only (n = 1), prevalent cases and seroconverters (n = 4), and prevalent cases only (n = 6). Superinfections were identified in 1 prevalent case and 2 seroconverters. The annual incidence of superinfection was higher among seroconverters than among prevalent cases, and was higher than the rate of primary HIV infection in the cohort. CONCLUSIONS: This report provides important insights into HIV genetic diversity, drug resistance, and superinfection among MSM and TGW in sub-Saharan Africa. These findings may help to inform future HIV prevention interventions in these high-risk groups.
引用
- Sivay MV, Palumbo PJ, Zhang Y, et al. Human Immunodeficiency Virus (HIV) Drug Resistance, Phylogenetic Analysis, and Superinfection Among Men Who Have Sex with Men and Transgender Women in Sub-Saharan Africa: HIV Prevention Trials Network (HPTN) 075 Study. Clin Infect Dis. 2021. PMID: 32761071. doi:10.1093/cid/ciaa1136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。